Tus kws kho mob
QP78-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective December 1, 2024
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3191 - 3200 ntawm 4374
Tus kws kho mob
QP84-24 Commercial Pharmacy Benefit Exclusion for Tremfya® and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP83-24 MHCP Pharmacy Benefit Exclusion for Tremfya®, Tecentriq Hybreza™ and Ocrevus Zunovo™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP82-24 Enhanced Authorization Submissions through Availity Essentials
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
QP80-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 13, 2024
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-effective-12-1-24.pdf
Kev Yuav Khoom thiab Kev Kawm Paub
2025 Spanish Individual & Family Decision Guide
Tus kws kho mob
2024 November Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P72-24 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
P70-24 Continuous Glucose Monitor Billing for Medicare Products
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024